Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448240
Status:
TERMINATED
Last Update Posted:
2010-02-02
First Post:
2007-03-14
Brief Title:
Erlotinib Tarceva During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2015-01
Completion Date Type:
ESTIMATED
First Submit Date:
2007-03-14
First Submit QC Date:
March 14 2007
Study First Post Date:
2007-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-02-01
Last Update Post Date:
2010-02-02
Last Update Post Date Type:
ESTIMATED